Search results for "platelet"

showing 10 items of 786 documents

Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral …

2021

AbstractThe aim of this collaborative document is to provide an update for clinicians on best antithrombotic strategies in patients with aortic and/or peripheral arterial diseases. Antithrombotic therapy is a pillar of optimal medical treatment for these patients at very high cardiovascular risk. While the number of trials on antithrombotic therapies in patients with aortic or peripheral arterial diseases is substantially smaller than for those with coronary artery disease, recent evidence deserves to be incorporated into clinical practice. In the absence of specific indications for chronic oral anticoagulation due to concomitant cardiovascular disease, a single antiplatelet agent is the ba…

medicine.medical_specialtyConsensusAntiplatelet drugmedicine.drug_classmedicine.medical_treatmentDisease030204 cardiovascular system & hematologyCoronary artery diseasePeripheral Arterial Disease03 medical and health sciences0302 clinical medicinePharmacotherapyFibrinolytic AgentsAntithromboticmedicineHumansIntensive care medicineAortabusiness.industryAnticoagulantAnticoagulantsThrombosismedicine.diseaseThrombosisCardiology and Cardiovascular MedicinebusinessPlatelet Aggregation Inhibitors030217 neurology & neurosurgeryFibrinolytic agentEuropean Heart Journal
researchProduct

Use of leukocyte and platelet-rich fibrin (L-PRF) in periodontally accelerated osteogenic orthodontics (PAOO): clinical effects on edema and pain

2015

Background Demand for shorter treatment time is common in orthodontic patients. Periodontally Accelerated Osteogenic Orthodontics (PAOO) is a somewhat new surgical procedure which allows faster tooth movement via combining orthodontic forces with corticotomy and grafting of alveolar bone plates. Leukocyte and Platelet-Rich Fibrin (L-PRF) possess hard- and soft-tissue healing properties. Further, evidence of pain-inhibitory and anti-inflammatory potential is growing. Therefore, this study explores the feasibility, intra- and post-operative effects of using L-PRF in PAOO in terms of post-operative pain, inflammation, infection and post-orthodontic stability. Material and methods A pilot prosp…

medicine.medical_specialtyDentistryInflammationOdontologíaFibrin03 medical and health sciences0302 clinical medicineEdemaBiomaterials and Bioengineering in DentistrymedicineGeneral DentistryDental alveolusOrthodonticsbiologybusiness.industryResearch030206 dentistry:CIENCIAS MÉDICAS [UNESCO]Complete resolutionCiencias de la saludPlatelet-rich fibrinSurgery030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASbiology.proteinmedicine.symptombusinessWound healingCorticotomy
researchProduct

CARDIOVASCULAR RISK IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA: THROMBOTIC RISK AND SURVIVAL

2019

Thromboembolic and bleeding events pose a severe risk for patients with Polycythemia Vera (PV) and Essential Thrombocythemia (ET). Many factors can contribute to promoting the thrombotic event due to the interaction between platelets, leukocytes, and endothelium alterations. Moreover, a significant role can be played by cardiovascular risk factors (CV.R) such as cigarette smoking habits, hypertension, diabetes, obesity and dyslipidemia. In this study, we evaluated the impact that CV.R plays on thrombotic risk and survival in patients with PV and ET .

medicine.medical_specialtyEndotheliumGastroenterologySettore MED/15 - Malattie Del Sangue03 medical and health sciences0302 clinical medicinePolycythemia veraInternal medicineDiabetes mellitushemic and lymphatic diseasesmedicinePlateletEssential ThrombocythemiaPolycythemia VeraThrombotic riskEssential thrombocythemiabusiness.industrylcsh:RC633-647.5Hematologylcsh:Diseases of the blood and blood-forming organsmedicine.diseaseObesityPolycythemia vera Essential ThrombocytemiaInfectious Diseasesmedicine.anatomical_structure030220 oncology & carcinogenesisOriginal ArticlebusinessDyslipidemia030215 immunologyMediterranean Journal of Hematology and Infectious Diseases
researchProduct

Efficacy and Safety of IQYMUNE®, a Ten Percent Intravenous Immunoglobulin in Adult Patients With Chronic, Primary Immune Thrombocytopenia

2018

Background: Intravenous immunoglobulin (IVIG) IQYMUNE® is a highly purified 10% IVIG that was assessed using the new stringent definition of response described in the revised guideline on the clinical investigation of IVIG. The efficacy and the safety of IQYMUNE® were investigated in adult patients with chronic primary immune thrombocytopenia (ITP). Methods: In this phase III multinational, multicentre, prospective, uncontrolled, open-label, single-arm study, adult patients with a baseline platelet count < 30 × 10 9 /L were treated with IVIG 10% at a dose of 2 g/kg body weight administered over 2 consecutive days. The primary endpoint was Response over the study period and was defined accor…

medicine.medical_specialtyEuropean Medicines Agency guidelinesPlatelet countRenal functionHigh dose030204 cardiovascular system & hematologyGastroenterology03 medical and health sciencesIntravenous immunoglobulin; High dose; Immune thrombocytopenia; Response; European Medicines Agency guidelines; Platelet count; Bleeding assessment; Infusion rate0302 clinical medicineInfusion rateInternal medicinemedicineClinical endpointPlateletAdverse effectIntravenous immunoglobulinbiologybusiness.industryResponseGuidelineImmune thrombocytopeniaImmune thrombocytopenia030220 oncology & carcinogenesisConcomitantbiology.proteinBleeding assessmentOriginal ArticleAntibodybusinessJournal of Hematology
researchProduct

Management of the Sponataneous Bleeding Episodes in Factor VII Deficiency. A Prospective Evaluation of the STER,

2011

Abstract Abstract 3368 Introduction Patients with an inherited factor VII (FVII) deficiency may display a wide range of clinical phenotypes, from an asymptomatic condition to serious hemorrhagic episodes such as fatal central nervous system (CNS) or gastrointestinal (GI) bleeds (Mariani G et al. Thromb Haemost 2005; 93: 481–7). Symptomatic patients can be divided into two major categories: those with mild-to-moderate bleeding tendency and individuals with a severe bleeding tendency which may be more severe than that in hemophilia. The former group mainly experience mucosal bleeding, a clinical picture that mimics that of a platelet disorder and often does not call for treatment. In contrast…

medicine.medical_specialtyFactor VIIbusiness.industryPlatelet disorderImmunologyCell BiologyHematologyBleedmedicine.diseaseHaemophiliaBiochemistryAsymptomaticGastroenterologySurgerychemistry.chemical_compoundHematomaHemophiliaschemistryInternal medicinemedicineFresh frozen plasmamedicine.symptombusinessBlood
researchProduct

Effectiveness of Leukocyte and Platelet-Rich Fibrin versus Nitrofurazone on Nail Post-Surgery Bleeding and Wound Cicatrization Period Reductions: A R…

2019

Background: Leukocyte and platelet-rich fibrin (L-PRF) may be considered a co-adjuvant intervention that may play a key role in blood coagulation and tissue repair after nail surgeries. The aim of this study was to determine the effectiveness of L-PRF versus nitrofurazone on the post-surgical bleeding and wound cicatrization period in patients with bilateral onychocryptosis during surgeries of chemical matrixectomies with 88% phenol solution. Methods: A randomized single-blind clinical trial was registered with the European Clinical Trials Database (EudraCT) with identification number 2016-002048-18. Twenty healthy participants with bilateral onychocryptosis (n = 40) were recruited and bila…

medicine.medical_specialtyFerides i lesions TractamentAnalgesicPainnail diseaseslcsh:MedicinePostoperatoriArticleFibrinsurgery030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinemedicineNail diseasespain030212 general & internal medicineplatelet rich plasmaInflammationNitrofurazonebiologybusiness.industrylcsh:RFoot and ankle surgeryGeneral Medicinemedicine.diseasePlatelet-rich fibrinSurgeryClinical trialExtremitatsmedicine.anatomical_structurePodologíaNail diseaseinflammationbiology.proteinNail (anatomy)EnfermeríaSurgeryPlatelet rich plasmabusinessJournal of Clinical Medicine
researchProduct

The impact of chocolate on cardiovascular health

2011

Cardiovascular disease is the leading determinant of mortality and morbidity in women. Functional foods are attracting interest as potential regulators of the susceptibility to disease. Supported by epidemiological evidence, chocolate has emerged as a possible modulator of cardiovascular risk. Chocolate, or cocoa as the natural source, contains flavanols, a subclass of flavonoids. The latter years have witnessed an increasing number of experimental and clinical studies that suggest a protective effect of chocolate against atherogenesis. Oxidative stress, inflammation, and endothelial function define three biological mechanisms that have shown sensitivity to chocolate. Moreover, the consumpt…

medicine.medical_specialtyFlavonolsmedicine.medical_treatmentCardiovascular healthPhysiologyDiseaseDark chocolateGeneral Biochemistry Genetics and Molecular BiologyfoodFunctional foodFunctional FoodmedicineAnimalsHumansInsulinWhite chocolateInflammationCacaomedicine.diagnostic_testbusiness.industryInsulinObstetrics and GynecologyCardiovascular AgentsPlatelet ActivationLipidsfood.foodSurgeryCardiovascular DiseasesNatural sourceEndothelium VascularPlant PreparationsbusinessLipid profilePhytotherapyMaturitas
researchProduct

Platelet Function Tests and Coronary Heart Disease

1984

It is well known that the formation of a platelet aggregate is the first step in an arterial thrombotic process.

medicine.medical_specialtyFramingham Risk ScoreEndotheliumPlatelet aggregationbusiness.industryeducationmedicine.diseaseCoronary heart diseasestomatognathic diseasesmedicine.anatomical_structurePlatelet function testPlatelet adhesivenessInternal medicinemedicineCardiologyPlateletMyocardial infarctionbusiness
researchProduct

The role of hemostatic devices in neurosurgery. A systematic review.

2021

Hemostasis represents a fundamental step in every surgical procedure. During neurosurgical procedures, proper and robust hemostasis into confined spaces can significantly reduce the odds of perioperative complications. Over the decades, multiple methods have been applied, and several medical devices have been developed to promote and guarantee proper hemostasis. This study presents a systematic review of the most used intraoperative hemostatic methods and devices in neurosurgery. Insightful research was performed on the PubMed database according to the PRISMA guidelines. This comprehensive review of scientific literature represents a synoptic panel where the most used intraoperative hemosta…

medicine.medical_specialtyGelatin foamBone waxMicrofibrillar collagenMultiple methodsOxidized celluloseHemostaticsNeurosurgical Procedures03 medical and health sciences0302 clinical medicinePlatelet-rich plasmaPhysiology (medical)medicineHumansIntensive care medicineBone waxGelatin spongesHemostasisFibrin sealantsbusiness.industryGeneral MedicinePerioperativeHemostasis SurgicalNeurology030220 oncology & carcinogenesisHemostasisSurgeryNeurology (clinical)NeurosurgeryNervous System Diseasesbusiness030217 neurology & neurosurgeryFibrin sealantsJournal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
researchProduct

Influence of spurious dilution and hyperglycemia on erythrocytes and platelets evaluated with two different hematological analyzers

2015

The integrity of whole blood samples may be compromised by suboptimal collection practices. Therefore, we investigated the influence of spurious hyperglycemia on erythrocytes and platelets, assessed with two hematological analyzers using optical or impedance technique. Three K2EDTA blood specimens were collected from 12 healthy subjects, pooled and divided into four aliquots. The first aliquot was left untreated (glucose concentration 4.4 mmol/L), whereas scalar amounts of standard 5% glucose solution were added to the remaining, generating glucose contamination of 5% (19.2 mmol/L), 10% (33 mmol/L) and 20% (62 mmol/L). Hematological testing was then performed using Siemens Advia 2120 and Sy…

medicine.medical_specialtyHealth Toxicology and MutagenesisBiomedical EngineeringMean corpuscular hemoglobinHematocritGeneral Biochemistry Genetics and Molecular BiologyArtificial IntelligenceInternal medicinemedicinehyperglycaemia erythrocytes plateletsPlateletGeneral Pharmacology Toxicology and PharmaceuticsMean platelet volumeWhole bloodGeneral Immunology and Microbiologymedicine.diagnostic_testMean corpuscular hemoglobin concentrationChemistryGeneral NeuroscienceRed blood cell distribution widthGeneral MedicineEndocrinologyImmunologyplateletserythrocytesHemoglobinGeneral Agricultural and Biological Scienceshyperglycaemia
researchProduct